=

Biogen to seek US approval for Alzheimer’s drug, sending shares soaring 40%

111111111

October 22, 2019 0 Comments
Biogen is planning to file for U.S. regulatory approval for its Alzheimer’s treatment aducanumab after fresh analysis of its clinical trial showed promise, the drugmaker said.
Tags:
Share: